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The human haploid genome contains a family of at least five 
different transglutaminases that are differentially expressed 
in time- and tissue-specific ways. Of these, trans glutaminase 
3 (TGase3) is unusual. in that it ~s .a pro-enzyme requiring 
activation by proteolysIs. To date It IS known to be expressed 
only in terminally d.ifferentiating epiderm~l ~nd hair follicle 
keratinocytes. In thiS paper we show that 1t 1S encoded by a 
gene (TGM3) of 42.8 ~bp containing 13 exollS. In the course 
of isolation of genomic clones for the TGM3 gene, we also 
found clones encoding the widely expressed tissue or TGase2 
enzyme, perhaps due to high degrees of sequence homology. 
The structure of the TGM2 gene has not yet been reported. 
Our incomplete data suggest its exon/intron organization is 
T ransglutaminases (TGases; protein-glutamine:amine y-glutamyltransferases, Ee 2.3.2.13) catalyze the for-mation of an NE(y-glutamyl)lysine isodipeptide cross-link in proteins between the y-amide of a donor gluta-mine and the E-NH2 of an acceptor lysine. The result 
is a stable, insoluble macromolecular structure, a process used 
widely throughout the plant and animal kingdoms [1- 5]. In 
humans, a family of five distinct TGases have been described to date 
(reviewed recently in [4 - 6]), including the catalytic a subunit of 
factor XIII; band 4.2, an inactive enzyme that forms a part of the 
subplasma membrane of animal cells; TGase1, a membrane-asso-
ciated enzyme present in many epithelial as well as some nOI1-
epithelial tissues; a ubiquitously expressed tissue TGase2; and 
a proezyme activiry, TGase.3, so fa: found only in terminally differ-
entiating epidermal and hair keratmocytes. Recently, a TGase4 ac-
tiviry was described in rat prostate [7], but it is not yet known 
whether it is also present in humans. All of these proteins show 
remarkable conservation of amino acid sequences and likely second-
ary structures, especially in the central two thirds of the molecule 
[6], a region that apparently describes their common catalytic prop-
erties. The enzymes differ from each other primarily in their amino-
and carboxyl-termini, for example, in factor XIlIa [8,9] and TGase1 
[6,10-12]' by recruitment of additional sequences that con-
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very similar to that ofTGM3. Although the common intron 
splice points of all members of the transglutaminase gene 
family have been conserved, the TGM3 and TGM2 genes, 
and the gene for the subplasma membrane trans glutaminase-
like protein band 4.2, lack two introns found in the TGM1 
and factor XlIIa genes, and the exact intron splice point of 
another intron is shifted with respect to that of the TGMl 
and factor XIIla genes. Based on sequence homologies and 
gene structures, the data support a phylogenie tree in which 
the TGM2 and TGM3 genes belong on a branch distinct 
from other transglutanunases. Key words: transglutaminase 2/ 
cell envelope/keratinization. ] Invest Dermatol 103:137-142, 
1994 
note specific properties and functions. The TGase3 is different in 
the sense that it is a pro-enzyme, requiring activation by proteolytic 
cleavage at a specific site about two thirds of the way long the 
molecule defined by a flexible hinge that is unique in the TGase 
family [13,14J. 
Not surprisingly, the known structures of the genes for three of 
the five human TGases have also been conserved in structure, thus 
indicating that the genes for the known extant family members 
arose from a common ancestor. The locations of most intron splice 
points have been conserved, although in comparison to the gene for 
band 4.2, the TGase1 and factor XIIIa genes possess two additional 
introns, one in 5'-untranslated regions and a second about 60% of 
the way along the coding sequences. 
However, less is known about the precise function(s) of these 
enzymes. Interestingly, the three active enzymes TGase1, TGase2, 
and TGase3 are expressed in the epidermis [14] . Whereas the ubiq-
uitous tissue or TGase2 activiry is thought to be involved in apopto-
sis [15-17], the TGase1 and TGase3 enzymes are thought to be 
involved in the construction of a cornified cell envelope during 
terminal differentiation that provides a vital barrier function for the 
tissue [18 - 20]. Expression data show that although the proTGase3 
mRNA is only about 2% as abundant as that for TGase1 [14], acti-
vated TGase3 nevertheless accounts for up to 75% of the total 
TGase activity in mamrnalian epidermis [13] . Accordingly, the 
characterization of the cD N A, protein, and gene structures of these 
three TGases is essential to understand their role(s) in the processes 
of normal and abnormal differentiation of the epidermis. We have 
recently described the fuIl-length cDNA structure of the TGase3 
system [14] and now describe in this paper its gene structure. During 
the isolation of genomic clones encoding fhe TGM3 gene, we also 
encountered clones encoding much of the TGM2 gene, and report 
here that both its gene structures are very similar to that of the 
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Figure 1. Organization of the human TGM3 gene. The upper line repre-
sents a schematic diagram of the gene showing the organization of exons 
(I-XIII) and introns (1-12). The positions of the likely regulatory se-
quences are illustrated. The secotld line denotes size scale. The tided line 
illustrates the four overlapping genomic clones used to assemble the gene 
structure. The 2-kbp PCR fragment that joins the clones gTGM3-2 and 
gTGM3-5 is shown. The lower line illustrates representative restriction en-
zyme sites used for the construction of the above maps. A, Aat 11; B, Bam HI; 
C, Cia I;E,Eco RI; K,Kptl I; S, Sph I; X,Xba I; andXh,Xho I. DiagnosticXl1O 
I and Aal II sites confirmed the overlap of clones gTGM3-6/gTGM3-2 and 
gTGM3-5/gTGM3-24. 
TGM3 system. The evolutionary significance of this finding is dis-
cussed. 
MATERIALS AND METHODS 
Molecular Biology Procedures A human placental genomic library 
constructed in the A-phage EMBL-3 vector (Clontech) was screened with a 
series of 15 synthetic oligonucleotides of 50 nt in length, corresponding to 
predicted e:cons, based on our full-length cDNA sequence for TGase3 
[6,14). A total of 12 genomic clones were thus identified and plaque purified. 
Each full-length insert was excised, subcloned into the pGEM-7z vector 
(Promega) and subjected to further restriction enzyme mapping. Primers for 
DNA sequencing with the Sequenase 2.0 system (U.S. Biochemical Corp.) 
on both strands were located in the predicted exon sequences to cross over 
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Table 1. Sizes of Exons and lntrons (in bp) 
of the Human TGM3 Gene 
Exon Intron 
Number Size Number Size" Method 
I 48b 13,400 PCR/mapping 
II 174 2 313 Sequencing 
III 240 3 600 PCR 
IV 119 4 1,800 PCR 
V 129 5 1,300 PCR 
VI 178 6 103 Sequencing 
VII 136 7 8,600 Mapping 
VIII 104 8 2,200 PCR 
IX 146 9 4,000 PCR/mapping 
X 309 10 3,300 PCR/mapping 
XI 158 11 4,000 PCR/mapping 
XII 134 12 500 PCR 
XlII 645' 
• Sizes ofintrons are estimated to be within 100 bp (except those determined exactly 
by sequencing). 
• Includes 44 bp of sequences from likely cap-site shown in Fig 2 to initiation codon 
plus 4 bp of coding sequences. 
( Includes from termination codon to polyadenylation signal sequence. 
exon-intron boundaries. Following these mapping and sequencing studies, 
we found that the available genomic clones did not encode exon 1. Accord-
ingly, we screened a different EMBL-3 human genomic library (lympho-
cyte, Clontech), and isolated another genomic clone as above that contained 
exon I and sequences upstream of the gene. A likely cap-site of the TGM3 
gene was established in an RNA-mediated anchored polymerase chain 
reaction (PCR) and characterization of the resulting sequence information 
(21). In addition, our avaiJable genomic clones did not comain exon V 
sequences. The gap encompassing exon V was closed by use of the PCR 
using as primers exon IV sequences at the 3' -end of clone gTGM3-2 and 
intron V scquenes at the 5' -end of clone gTGM3-5 (see below and Fig 1). All 
PCR reactions were done with the Perkin Elmer-Cetus amplification kit 
using 25 pmol of primers and with conditions of 95 °C (5 min), aJ1d 35 cycles 
of denaturation at 94°C (0.5 min) , annealing at 42°C (0.5 min), and elonga-
tion at 72°C (1.5 min). The products were fractionated through a 4% 
low-melting agarose gcl, excised, and purified through Chroma spin 100 
columns (Clontech). The ends of the amplified DNA were filled in with the 
Table II. Splice Donor and Acceptor Sequences Used ill the Human TGM3 Gene" 
Donor Sequence 
A A 
CGAAACATGGCTGgtgagtgcatggcatcttctccatcaggtc 
I V S T G 
A TTGTGTCCACAGgtacctgctcattcccctccttgcccaaac 
p W L N V 
CCCTGGCTGAA TGgtaggtgtctagccacccacactctcagcc 
N F G Q 
GAA CTTTGG ACAGgtaaaatcataaggaataccatctccacca 
L SAM 
GCTGAGTGCCA TGgtgagtaacatggtcaatgctgtcaggctg 
T L N T A 
ACCCTCAACACAGgtaccttgggtgtggtgtgccttggctggg 
D S V W 
GTGAT AGCGT ATGgtaagtatctcaccttttccctgaacttcg 
E R S Q G 
GAAAGAAGCCAAGgtaacttctctgggtgtggttctgagtcgt 
K Y PEG 
AAGTACCCAGAAGgtaggagggacgctggcggggcagtgcgcg 
D PEE E 
GACCCTGAGGAAGgtaacgcatcccgcagttggaggagatcca 
L T L E 
CTTGACCCTGGAGgtaatggggttcccccatcctgtgggaagg 
L KID 
ACCTG AA GA TCG Agtgagtcctgggcctaagtggcggtgcagg 
lntron Number 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Acceptor Sequence 
L G V Q 
taggacttcaggttcgccttctgcatgcagCTCTAGGAGTCCAG 
P Y P S 
gttggttttctcaacctctgtctttgacagGGCCTT ACCCCTCA 
D S V F 
tcgctggtgtctgctttttgtatcaaatagTGGA T AGCGTCTTT 
FEE D I 
aattgtaatgtatggtctcgttctgaacagTITGAAGAAG ACA T 
INS N D 
ctcattttgggggggtggtttctggcccagA TCAA TAGCAA TGA 
L R S L 
ctgagtcctcacgcccaccctgacttgcagCGCTGCGGTCTTTG 
N F H V W 
aaatgagtgggacacagtcaggggctgaagG AA TITCCA TGTCT 
V F Q C 
attccagcctctgcgcatcttggcctccagGGGTGTTCCAGTGC 
S D Q E 
gcatgtttgtcgtcttttcccaccacacagGCTCTGACCAGGAA 
A E H P 
tcactcggatcccctggcttctccttccagAGGCAGAACATCCC 
V L N E A 
tcctgactcggcagcccctctcccccatagGTGCTGAACGAGGC 
V P T L G 
atcaacactgatctgtgccctccccatcagCGTGCCGACCCTAG 
• The sequences of the 5' -splice donor (left column) and 3' -splice acceptor sites are shown for each intron. Coding sequences are in capital letters; intron sequences are in lowerc= 
letters . •. initiation codon . 
VOL. 103, NO.2 AUGUST 1994 
'CA T bozcs ' 
CTACAGG~ACCTGGTGC CTCGCCCACT T~AGAAT TCTAATTGGG GTGTGTAGGA - 61 
TJ\TAbox ' 
GAGGATTC~TGGTAA GGCAATCCTT GGCAGCCTGT CTGTCAGCAC TGTCCGTGCC - 1 
1:"100 1-, rinrr on J 
ATTCCCAGAG GAGCCTGAGA AG/\GGC AGAG GAAGGCGAAA CATGGCTGgt gagtgcatac +60 
. 1. J'-l! ztcllt o( clJNA = 
Figure 2. Structure of the 5'-end of the human TGM3 gene. The sequence 
of the genomic clone g-TGM3-6 immediately upstream of the likely initia-
tion codon was determined and found to be almost identical to the available 
cDNA information adduced previously [14). By both computer predictions 
and RNA-mediated anchored-PCR primer extension experiments, the indi-
cated cap-site is the most likely site of initiation of transcription. Nearby 
likely TATA and CAT boxes identified in genomic sequences are Iwderlined. 
The initiation codon is double Iwderli"ed. The 5'-extent of the cDNA infor-
mation (14) is shown, as is also the splice point of intron 1. 
Klenow DNA polymerase, and subcloned into the pGEM-3z vector for 
sequencing (14). 
COD1puter Analyses of Sequences Nucleic acid and protein sequence 
homologies were performed using the University of Wisconsin software 
packages compiled by the Wisconsin Genetics Computer Group [22) and the 
illr Pustell sequence (version 3.5, International Biotechnologies Inc) [23,24) 
or Geneworks (Intelligenics) [25) software. A phylogenic tree was estab-
lished as described [26J. 
RESULTS AND DISCUSSION 
Isolation of Genomic Clones Encoding the TGM3 Gene 
Recent data have established that the locations of the exon/intron 
boundaries of the genes for three of five members of the human 
TGase family have been largely conserved [6,10,11,27,28]' Based 
on the assumption that the structure of the TGM3 gene is also 
similar, a series of synthetic oligonucleotides 50 nt long corre-
sponding to predicted exon regions was used to probe a human 
placental genomic lib~ary, from which 12 gen~mic clones were 
isolated and plaque punfied. Each cross-reacted WIth one or more of 
the synthetic oligonucleotides, except the probes designed for exons 
I and V. Each genomic clone was subjected to further restriction 
enzyme mapping and sequencing across the predicted exon/intron 
boundaries. Several clones were found to be identical. In this way, it 
was established that most of the TGM3 gene was encoded by the 
three genomic clones in 5' to 3' order of gTGM3-2 (14.2 kbp), 
gTGM3-5 (16.0 kbp), and gTGM3-24 (13.2 kbp) (Fig 1). Confir-
mation of a 1.8-kbp overlap between gTGM3-5 and gTGM3-24 
was established by both restriction enzyme mapping and by hybrid-
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izations of other additional oligonucleotides located at the 3' and 5' 
ends of these clones, respectively. However, it was clear that a gap 
existed between clones gTGM3-2 and gTGM3-5, encompassing 
likely exon V sequences. This gap, in intron sequences, was found to 
be only 1.8 kbp long by use of a PCR experiment, using primers 
located at the 3' and 5' ends of these two clones, and total genomic 
DNA isolated from the human placental library as template. Subse-
quent hybridization and direct sequencing established that exon V 
sequences were present in the amplified fragment. The 5' extent of 
the clone gTGM3-2 began in intron 1 sequences and did not contain 
exon I. Accordingly, a different human (lymphocyte) genomic li-
brary was screened. The 18-kbp clone gTGM3-6 was isolated, char-
acterized and found by PCR and restriction enzyme mapping to 
overlap gTGM3-2 by about 10 kbp (Fig 1). By PCRanalysis, exon I 
sequences were located on gTGM3-6 about 2.2 kbp above the 5' 
extent of gTGM3-2, so that intron 1 is about 13.4 kbp long (Table 
I) . Thus gTGM3-6 contains about 6 kbp of flanking sequences 
above the likely cap site of the TGM3 gene (Fig 1). 
Accordingly, it was possible to assemble the full-length gene by 
this combination of direct sequencing, sequencing across exon/in-
tron boundaries, and restriction enzyme mapping. In most cases, a 
close approximation of the sizes of introns was confirmed by addi-
tional PCR experiments. The sizes of the longest introns 1 and 6 
could be estimated only from the sizes of restriction enzyme frag-
ments and/or PCR products. The TGM3 gene consists of 13 exons 
and 12 introns, as summarized in Table I. All of the junctions con-
form to consensus splice donor/acceptor boundaries [29] (Table II). 
During the course of this work, we resequenced the entire coding 
portion of the human TGM3 gene, and found four sequence differ-
ences with respect to the cDNA sequence [14], in codons 12 (AAA 
to ACA, lysine to threonine); 260 (AAA to ACA, lysine to threon-
ine); 264 (TTC to CTC, phenylalanine to leucine); and 299 (GCT 
to CCT, alanine to proline). These are most likely simple sequence 
polymorphisms, for the following reasons. First, even though the 
entire cDNA sequences had been adduced by repeated PCR proce-
dures and required resolution of seven ambiguous nt [14], none of 
the variations found in this study had been seen in the previous 
replicate PCR experiments. Second, we showed that the cDNA 
sequences directed the expression of an active TGase3 pro-enzyme 
protein in yeast [14]. Each of these amino acid substitutions occurs 
in regions predicted to form protein turns or n loops [6,22] . Thus 
the variations observed here in the TGM3 gene are polymorphisms 
in the human population that do not affect enzyme function or 
activity. 
When compared with the available cDNA information, intron 1 
Table III. Known Splice Donor and Acceptor Sequences Used in the Human TGM2 Gene" 
Donor Sequence 
A E E 
ACCA TGGCCGAGGgtcgccacactcccaggtaccatagttcta 
V V T G 
GTGTCGTGACCGGgtgagtacctgcaaccccactccaccacca 
A W CPA 
GCCTGGTGCCCAGgtcctccactggctaccagggatccagctt 
N F G Q 
GAATTTTGGGCAGgtagggccacaccctgcctctcccaaccat 
GSA M 
GGGT AGTGCCA TGnnnnnnnnnn 
V ACT V 
GTGGCCTGCACAGgtgagctgcagctgggatgtgggtcatgag 
E M I W 
GCGAGA TGA TCTGgtgaggtgggccagggtgggacggagccca 
E K S E G 
GAGAAGAGCGAAGgtgcgtgggcgggcactgtcgcgtcaaaca 
K Y P E 
CAAA T ACCCAGAGgatgttgccctcagggtcttaagcagcctt 
Intron Number 
2 
3 
4 
5 
6 
7 
8 
9 
Acceptor Sequence 
L V L E 
ggctcatgcgtctccttctgttttccatagAGCTGGTCTT AGA 
PAP S 
tgctcacggctactgcttctccctccacagGCCAGCCCCTAGC . 
D A V Y 
cagagctgaggtccctttcttcctgcctagCGGA TGCTGTGT A 
F Q D G I 
nnnnJlnnnnnTTTCAAGATGGGA 
V N C N C 
ctcgtccccgtgctgccccactggttgcagGTCAACTGCAACT 
., L R C L 
ctcaccccgctttccactcctctccaacagTGCTGAGGTGCCT 
N F H C 
tgcttcattcccgccccccatccccctcagG AA CTTCCACTGC 
T Y C C 
tcccgcccttcccctttctacctctgccagGAACGT A CTGCTG 
Not lmown 
• The sequences of the 5'-splice donor (left cO/UnltJ) and 3'-splicc acceptor sites arc shown for each intron. Coding sequences 3fC in capital letters; intran sequences arc in lower case 
letters. " initiation codon. n, unknown intron sequences around expected exon V. hltron splice points for expected exons V and X to XIII are not known, due to unavailable gene 
clone information. 
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Figure 3. Comparison of the gene structures of several TGase-like pro-
teins. Protein sequences are aligned to maximize homologies [25]. The 
known positions of the intron splice points in the genes arc designated by 
closed arrow/leads. The predicted locations of the other intron splice points in 
the TGM2 gene are designated by open arrowheads. h, human; m, mouse; hF, 
human factor XIIla; h4.2, human band 4.2. 
splices 4 bp downstream from the consensus initiation codon, so 
that exon I consists mostly of 5' -untranslated sequences (Fig 2). The 
genomic and available cDNA sequences differed by only one nt in 
the 5'-untranslated region. Further sequencing on the genomic 
clone upstream revealed a likely cap-site 1 nt above the available 
cDNA information, as predicted by computer programs. The avail-
able cDNA information had been adduced by use of RNA-mediated 
anchored-PCR primer-extension experiments [14]. In an attempt to 
confirm this potential cap-site, we performed additional experi-
ments with different batches of foreskin epidermal RNA, and using 
primers located at the confirmed beginning of the exon II se-
quences. We obtained amplified products that extended to the same 
place, within 1nt of the indicated cap-site of Fig 2, so that exon I is 
likely to be only 48 bp in length. Attempts to rigorously prove this 
as a functional cap-site by use of RNAse protection experiments 
with human foreskin RNA with a 32P-Iabeled 4.3-kbp Xho I - Sph I 
fragment were unsuccessful. We think the most likely reason for 
this is the very low abundance of the mRNA encoding the TGase3 
in the epidermis [14], and because the resulting exon I is only 48 bp, 
perhaps too short to confidently prove by this method [21,30]. 
However, in further good support of our model, a consensus T AT A 
box exists at -52 nt and two consensus CAT boxies exist at -89 nt 
and -113 nt (opposite strand) (Fig 2) . Additional functional assays 
involving reporter gene elements will be necessary to prove this 
model. 
Altogether, these present data suggest that the human TGM3 
gene is approximately 42.8 kbp long (Table I) , about twice the 
length of the gene for the band 4.2 protein [27], three times longer 
than the TGM1 gene [6], but much shorter than the gene for the 
factor XlIIa [28]. 
Discovery and Partial Characterization of Genomic Clones 
for the TGM2 Gene However, three other genomic clones, 
which hybridized strongly to oligonucleotides designed from our 
known full-length cDNA for TGase3, clearly did not encode the 
TGM3 gene. Sequence comparisons established that they encoded 
TGase2 sequences instead [27]. The TGM2 gene structure has not 
been reported yet. Partial restriction enzyme mapping analyses in-
dicate that most of the TGM2 gene is encoded by the three clones 
gTGM2-7 (13 kbp, containing exons I, II, III, and IV), gTGM2-10 
(15 kbp, containing exons VI, VII, and VIII) , and gTGM2-3 (13 
kbp, containing exon IX) . We were unable to close a gap between 
clones gTGM2-7 and gTGM2-10 containing exon V sequences by 
use of PCR methods, as described above for the TGM3 gene, per-
haps suggesti~g that introns 4 and/or 5 are much larger than in the 
TGM3 gene. Nor does the clone gTGM2-3 contain expected exom 
X-XIII. Comparisons of the sequence of the clone gTGM2-7 with 
the available cDNA information encoding TGase2 [27] indicates 
that the TGM2 gene does not contain an intron in 5' -untranslated 
sequences. Sequencing across all of the available exon/intron 
boundaries reveals (Table III) that the introns splice at positions thar 
are conserved with respect to the TGM3 gene. Thus although the 
exons are of similar size, it seems likely that the TGM2 gene is 
larger than the TGMl or TGM3 genes due to relatively larger 
introns. Also, all of the known junctions again conform to consen-
sus splice donor/acceptor boundaries (Table III). 
Conservation of the Structures of the Genes of the Transglu. 
taminase Family Figure 3 shows an updated homology align-
ment of available TGase proteins, and includes the newly described 
rat prostate TGase4 enzyme [7] and an invertebrate TGase protein 
from the grasshopper, termed annulin [31]. Several points are note-
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TGM2 
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TGM3 
(2Oq11) 
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(6p24) 
Figure 4. Phylogenie tree of the know n human TGases. Using the. neigh-
bor-joining method [26] one pOSSIble rooted tree IS Lllustrated, and IS based 
on amino acid sequence homology scores and gene structures. Our new data 
confirm and extend an earlier hypothesis [11]. Two main branches are pos-
tulated, one including the genes for TGMI and factor XIIla, and a second 
containing the genes for band 4.2, TGM2, and TGM3. Because of their high 
degrees of homology, it is thought that the genes for TGM2 and TGM3 
duplicated more recently from an ancestor in common with band 4.2. This 
view seems to be supported by the chromosomal locations of the five genes 
(shown in parentheses). 
w orthy. First, most intron positions have been precisely conserved. 
Second, the TGM1 and factor XIIIa genes have two additional 
introns: one in 5' -untranslated sequences; and another about 60% of 
the way along the coding sequences that splices exon VIII of the 
TGM2, TGM3, and band 4.2 genes. In addition, although the in-
tron 12 splice point of the TGM3 gene is located in the same place as 
that of the gene for band 4.2, it is 6 nt upstream of the position of the 
corresponding intron splice point in the TGM1 and factor XIIIa 
gen es . 
Furthermore, as pointed out earlier [6], sequence and likely sec-
ondary structures between the regions spanned by introns 1 and 11 
(for TGM2, TGM3, and band 4.2 genes) or 2 and 13 (for TGM1 
and factor XIIla genes) have been conserved, not only in all of the 
mammalian TGases but also in the invertebrate protein arumlin. 
Homology scores using existing algorithms [24,25] suggest the 
TGase3 protein is closely related to TGase2 and TGasel, and more 
distantly related to factor XIIIa and band 4.2. Similarly, the rat 
TGase4 protein shows higher sequence homology to the human 
TGasel and factor XIIIa proteins. TGase3 differs from all other 
members of the TGase gene family primarily by the net insertion of 
12 residues that serve as a flexible hinge at its site of proteolytic 
activation (Fig 3) [14]. 
Evolution of the TGM3 Gene System. The above new data on 
the likely structures of the TGM3 and TGM2 genes, together with 
their high degrees of sequence homology, allow a model for the 
evolution of the family of human TGases [26]. These data support 
and extend the notion [11] that an early or primordial gene diverged 
into two branches (Fig 4). One branch contains the TGMl and 
factor XlIIa genes that have acquired an additional exon of se-
quences on their 5' -ends to connote specialized properties of mem-
brane association (for TGasel [32]) or proteolytic activation (for 
factor XlIIa [8,9]), and have either gained or retained an intron at 
about 60% along the coding sequences. A second branch includes 
the genes for band 4.2, TGM2 and TGM3 that may have never 
recruited an extra exon in 5' -untranslated sequences, may have lost 
an intron 60% along the coding sequences, and at least two mem-
bers, possibly also the TGM2 gene, have moved the last intron 
splice point. We suggest that the TGM2 and TGM3 genes may be 
more modern members of the human TGase family in the sense that 
they have more recently duplicated, so that their organization and 
coding sequences are still highly homologous. This map is also 
consistent with the chromosomal locations of the TGase genes (Fig 
4). Preliminary datat have shown that the TGM2 and TGM3 genes 
are tightly linked and map to chromosome 20. In contrast, the genes 
for factor XIIla, band 4.2, and TGM1 have been scattered on the 
t W ang M, Kim I-G, Steinert P, McBride OW (unpnblished observa-
tions). 
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human genome, to chromosome positions 6p24-34 [33]. 15q15 
[34], and 14ql1.2 [6 ,12]' respectively, thereby supporting the view 
that the TGM2 and TGM3 genes have most recently duplicated and 
have not yet scattered on the genome. The gene for band 4.2 has a 
lower overall sequence homology, but this may be because it is not a 
functional enzyme and so there has been less selective pressure for 
sequence conservation [11]. Placement of TGase4 on the phylo-
genic tree of Fig 4 should await determination of its gene structure; 
that is, whether or not it contains the two additional introns and one 
displaced intron splice point common to the TGM 1 and factor 
XIII a genes. 
In conclusion, the present data describe for the first time the 
organization of the TGM3 gene, and establish it to be most similar 
in terms of structure to the TGM2 gene, not the three other pres-
ently known human TGase genes. 
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